Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 125

1.

New Insights and Methods in the Approach to Thalassemia Major: The Lesson From the Case of Adrenal Insufficiency.

Poggi M, Samperi I, Mattia L, Di Rocco A, Iorio C, Monti S, Pugliese G, Toscano V.

Front Mol Biosci. 2020 Jan 29;6:162. doi: 10.3389/fmolb.2019.00162. eCollection 2019.

2.

Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment.

Orsi E, Bonora E, Solini A, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Zerbini G, Morano S, Nicolucci A, Penno G, Pugliese G.

J Clin Med. 2020 Jan 17;9(1). pii: E246. doi: 10.3390/jcm9010246.

3.

Study to Weigh the Effect of Exercise Training on BONE quality and strength (SWEET BONE) in type 2 diabetes: study protocol for a randomised clinical trial.

Balducci S, Conti F, Sacchetti M, Russo CR, Argento G, Haxhi J, Orlando G, Rapisarda G, D'Errico V, Cardelli P, Pugliese L, Laghi A, Vitale M, Bollanti L, Zanuso S, Nicolucci A, Pugliese G; SWEET BONE Investigators.

BMJ Open. 2019 Nov 4;9(11):e027429. doi: 10.1136/bmjopen-2018-027429.

4.

Muscle fatigability in patients with type 2 diabetes: relation with long-term complications.

Orlando G, Sacchetti M, D'Errico V, Haxhi J, Rapisarda G, Pugliese G, Balducci S.

Diabetes Metab Res Rev. 2020 Feb;36(2):e3231. doi: 10.1002/dmrr.3231. Epub 2019 Nov 11.

PMID:
31670895
5.

Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".

Pugliese G, Penno G, Natali A, Barutta F, Di Paolo S, Reboldi G, Gesualdo L, De Nicola L; Italian Diabetes Society and the Italian Society of Nephrology.

Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1127-1150. doi: 10.1016/j.numecd.2019.07.017. Epub 2019 Oct 2. Review.

PMID:
31586514
6.

Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".

Pugliese G, Penno G, Natali A, Barutta F, Di Paolo S, Reboldi G, Gesualdo L, De Nicola L; Italian Diabetes Society and the Italian Society of Nephrology.

J Nephrol. 2020 Feb;33(1):9-35. doi: 10.1007/s40620-019-00650-x. Review.

7.

Invest in METs, Not in Meds.

Haxhi J, Balducci S, Pugliese G.

Am J Med. 2019 Oct;132(10):e756. doi: 10.1016/j.amjmed.2019.05.038. Epub 2019 Jul 19. No abstract available.

PMID:
31331613
8.

L-carnosine and its Derivatives as New Therapeutic Agents for the Prevention and Treatment of Vascular Complications of Diabetes.

Menini S, Iacobini C, Fantauzzi CB, Pugliese G.

Curr Med Chem. 2019 Jul 10. doi: 10.2174/0929867326666190711102718. [Epub ahead of print]

PMID:
31296153
9.

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier).

Casadei-Gardini A, Montagnani F, Casadei C, Arcadipane F, Andrikou K, Aloi D, Prete AA, Zampino MG, Argentiero A, Pugliese G, Martini S, Iorio GC, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Marisi G, Dell'Acqua V, Ravenda PS, Lonardi S, Silvestris N, De Bari B, Ricardi U, Cascinu S, Franco P.

Cancer Manag Res. 2019 Apr 26;11:3631-3642. doi: 10.2147/CMAR.S197349. eCollection 2019. Erratum in: Cancer Manag Res. 2019 Jun 25;11:5123.

10.

Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study.

Solini A, Penno G, Orsi E, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Lamacchia O, Baroni MG, Nicolucci A, Pugliese G; Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.

BMC Med. 2019 Apr 25;17(1):83. doi: 10.1186/s12916-019-1313-x.

11.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators.

Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Erratum in: Lancet. 2019 May 11;393(10184):1936.

PMID:
30995972
12.

Effect of a Behavioral Intervention Strategy on Sustained Change in Physical Activity and Sedentary Behavior in Patients With Type 2 Diabetes: The IDES_2 Randomized Clinical Trial.

Balducci S, D'Errico V, Haxhi J, Sacchetti M, Orlando G, Cardelli P, Vitale M, Bollanti L, Conti F, Zanuso S, Lucisano G, Nicolucci A, Pugliese G; Italian Diabetes and Exercise Study 2 (IDES_2) Investigators.

JAMA. 2019 Mar 5;321(9):880-890. doi: 10.1001/jama.2019.0922.

PMID:
30835309
13.

Preoperative atorvastatin reduces bleeding and blood transfusions in patients undergoing elective isolated aortic valve replacement.

Nenna A, Spadaccio C, Lusini M, Nappi F, Mastroianni C, Giacinto O, Pugliese G, Casacalenda A, Barbato R, Barberi F, Greco SM, Satriano U, Forte F, Miano N, Colicchia C, Di Lorenzo D, Gaudino M, Chello M.

Interact Cardiovasc Thorac Surg. 2019 Jul 1;29(1):51-58. doi: 10.1093/icvts/ivz012.

PMID:
30753487
14.

Management of diabetes mellitus in patients undergoing liver transplantation.

Grancini V, Resi V, Palmieri E, Pugliese G, Orsi E.

Pharmacol Res. 2019 Mar;141:556-573. doi: 10.1016/j.phrs.2019.01.042. Epub 2019 Jan 25. Review.

PMID:
30690071
15.

Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients.

Grancini V, Trombetta M, Lunati ME, Boselli ML, Gatti S, Donato MF, Palmieri E, Resi V, Pugliese G, Bonadonna RC, Orsi E.

J Hepatol. 2019 May;70(5):954-962. doi: 10.1016/j.jhep.2019.01.015. Epub 2019 Jan 21.

PMID:
30677460
16.

Beyond the Beyond: A Case of an Extraordinary Response to Multiple Lines of Therapy in a de novo Metastatic HER2-Negative Gastric Cancer Patient.

Baldessari C, Gelsomino F, Spallanzani A, Pugliese G, Reggiani Bonetti L, Bettelli S, Cascinu S.

Gastrointest Tumors. 2018 Sep;5(1-2):14-20. doi: 10.1159/000488983. Epub 2018 Jul 27. Review.

17.

Metabolically healthy versus metabolically unhealthy obesity.

Iacobini C, Pugliese G, Blasetti Fantauzzi C, Federici M, Menini S.

Metabolism. 2019 Mar;92:51-60. doi: 10.1016/j.metabol.2018.11.009. Epub 2018 Nov 17. Review.

PMID:
30458177
18.

The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial.

Saglimbene V, Palmer SC, Ruospo M, Natale P, Maione A, Nicolucci A, Vecchio M, Tognoni G, Craig JC, Pellegrini F, Lucisano G, Hegbrant J, Ariano R, Lamacchia O, Sasso A, Morano S, Filardi T, De Cosmo S, Pugliese G, Procaccini DA, Gesualdo L, Palasciano G, Johnson DW, Tonelli M, Strippoli GFM; Long-Term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) Investigators.

J Am Soc Nephrol. 2018 Dec;29(12):2890-2899. doi: 10.1681/ASN.2018040443. Epub 2018 Nov 12.

19.

Variability in genes regulating vitamin D metabolism is associated with vitamin D levels in type 2 diabetes.

Bertoccini L, Bailetti D; SUMMER Study in Diabetes Group, Buzzetti R, Cavallo MG, Copetti M, Cossu E, D'Angelo P, De Cosmo S, Di Mauro L, Leonetti F, Morano S, Morviducci L, Napoli N, Prudente S, Pugliese G, Trischitta V, Baroni MG.

Oncotarget. 2018 Oct 9;9(79):34911-34918. doi: 10.18632/oncotarget.26178. eCollection 2018 Oct 9.

20.

Issue focusing: a new topical collection on diabetic nephropathy.

Pugliese G, Porta M.

Acta Diabetol. 2018 Nov;55(11):1091-1092. doi: 10.1007/s00592-018-1228-6. Epub 2018 Sep 12. No abstract available.

PMID:
30206699

Supplemental Content

Loading ...
Support Center